| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| CANTEX PHARMACEUTICALS, INC. | 10%+ Owner | $3,343,550 | 14 Sep 2021 | ||
| Michael T. Andriole | PRESIDENT AND CEO, Director | $0 | 21 Apr 2025 | ||
| Michael Alrutz | Svp And General Counsel | $0 | 21 Apr 2025 | ||
| Michelle LaSpaluto | Chief Financial Officer | $0 | 21 Apr 2025 | ||
| Allen S. Melemed | Chief Medical Officer | $0 | 21 Apr 2025 | ||
| FRED A. MIDDLETON | Director | $0 | 21 Apr 2025 | ||
| Robert J. Meyer | Director | $0 | 21 Apr 2025 | ||
| Michael A. Sherman | Chief Executive Officer, Director | $0 | 21 Apr 2025 | ||
| MARTHA J. DEMSKI | Director | $0 | 21 Apr 2025 | ||
| Thomas J. Riga | COO and CCO | $0 | 21 Apr 2025 | ||
| David Jakeman | Vp Of Finance And Accounting | $0 | 21 Apr 2025 | ||
| MARC D. KOZIN | Director | 21 Apr 2025 | |||
| Pratik S. Multani | Director | 21 Apr 2025 | |||
| Lisa Lynn Decker | Director | 21 Apr 2025 | |||
| Catherine Gilliss | Director | 09 Jun 2023 | |||
| Patrick Machado | Director | 09 Jun 2023 | |||
| Victoria Vakiener | Director | 21 Apr 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|